A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease von Yacyshyn, Bruce R., Bowen-Yacyshyn, Mary Beth, Jewell, Lawrence, Tami, Joseph A., Bennett, C.Frank, Kisner, Daniel L., Shanahan, William R.

Volltext

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active ster... von Yacyshyn, B R, Chey, W Y, Goff, J, Salzberg, B, Baerg, R, Buchman, A L, Tami, J, Yu, R, Gibiansky, E, Shanahan, W R

Volltext

Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease von Yacyshyn, B. R., Barish, C., Goff, J., Dalke, D., Gaspari, M., Yu, R., Tami, J., Dorr, F. A., Sewell, K. L.

Volltext

Prevalence of Occult Gastrointestinal Bleeding in Celiac Disease von Mant, Michael J., Bain, Vincent G., Maguire, Conor G., Murland, Keith, Yacyshyn, Bruce R.

Volltext

The Clinical Importance of Proton Pump Inhibitor Pharmacokinetics von Yacyshyn, B.R., Thomson, A.B.R.

Volltext

CD45RO expression on circulating CD19 + B cells in Crohn's disease correlates with intestinal permeability von Yacyshyn, Bruce R., Meddings, Jon B.

Volltext

Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM‐1 von Yacyshyn, B. R., Schievella, A., Sewell, K. L., Tami, J. A.

Volltext

Discussion on the safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study von Yacyshyn, Bruce R, Pilarski, Linda M

Volltext

The concept and application of antisense oligonucleotides von Yacyshyn, Bruce R, Crooke, Stanley T

Volltext

Critical Review of Acid Suppression in Nonvariceal, Acute, Upper Gastrointestinal Bleeding von Yacyshyn, B.R., Thomson, A.B.R.

Volltext

Preclinical and clinical pharmacology of antisense oligonucleotides von MARCUSSON, E. G, YACYSHYN, B. R, SHANAHAN, W. R, DEAN, N. M

Volltext

Drug treatment for Crohn's disease von Yacyshyn, Bruce R

Volltext

Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero von PILARSKI, L. M, YACYSHYN, B. R, LAZAROVITS, A. I

Volltext

Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns von Yacyshyn, Bruce R., Lazarovits, Andrew, Tsai, Vance, Matejko, Katarzyna

Volltext

Inhibition by Rapamycin of P‐Glycoprotein 170‐Mediated Export from Normal Lymphocytes von Yacyshyn, B. R., Bowen‐Yacyshyn, M. B., Pilarski, L. M.

Volltext

Multidrug resistant protein (MRP) expression and function is greater in uc than Crohn's disease in contrast to PGP-170 von Bowen-Yacyshyn, MB, Yacyshyn, BR

Volltext

New biotechnological therapies for Crohn's disease: where are we now? von Yacyshyn, B R

Volltext

Making sense of antisense von Yacyshyn, B R, Shanahan, Jr, W R

Volltext

Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease von Yacyshyn, B R, Pilarski, L M

Volltext

Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression von Pilarski, LM, Yacyshyn, BR, Jensen, GS, Pruski, E, Pabst, HF

Volltext